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Background: Fungal skin infections associated with Ophidiomyces ophiodiicola, a member of the Chrysosporium
anamorph of Nannizziopsis vriesii (CANV) complex, have been linked to an increasing number of cases of snake
fungal disease (SFD) in captive snakes around the world and in wild snake populations in eastern North America.
The emergence of SFD in both captive and wild situations has led to an increased need for tools to better
diagnose and study the disease.
Results: We developed two TaqMan real-time polymerase chain reaction (PCR) assays to rapidly detect O.
ophiodiicola in clinical samples. One assay targets the internal transcribed spacer region (ITS) of the fungal
genome while the other targets the more variable intergenic spacer region (IGS). The PCR assays were qualified
using skin samples collected from 50 snakes for which O. ophiodiicola had been previously detected by culture,
20 snakes with gross skin lesions suggestive of SFD but which were culture-negative for O. ophiodiicola, and 16
snakes with no clinical signs of infection. Both assays performed equivalently and proved to be more sensitive
than traditional culture methods, detecting O. ophiodiicola in 98% of the culture-positive samples and in 40% of
the culture-negative snakes that had clinical signs of SFD. In addition, the assays did not cross-react with a panel
of 28 fungal species that are closely related to O. ophiodiicola or that commonly occur on the skin of snakes. The
assays did, however, indicate that some asymptomatic snakes (~6%) may harbor low levels of the fungus, and
that PCR should be paired with histology when a definitive diagnosis is required.
Conclusions: These assays represent the first published methods to detect O. ophiodiicola by real-time PCR. The
ITS assay has great utility for assisting with SFD diagnoses whereas the IGS assay offers a valuable tool for
research-based applications.
Keywords: Chrysosporium anamorph of Nannizziopsis vriesii (CANV), Emerging disease, Ophidiomyces
ophiodiicola, Real-time PCR, Snake fungal diseaseBackground
Skin infections are among the most common diseases
observed in captive snakes [1,2]. While fungi are often
implicated in many of these infections through histo-
pathologic analyses, identifying the exact causative agent
can be difficult. Traditionally, culture analyses were the
standard for determining the likely causes of dermato-
mycoses, but such analyses are complicated by the* Correspondence: dblehert@usgs.gov
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skin of reptiles [2,3]. In addition, relatively little work
has been conducted to identify which of these fungi are
medically important [2]. The veterinary literature con-
tains numerous case reports implicating particular fungi
as the causes of dermatitis in snakes, but few offer com-
pelling evidence that the fungi grown in culture truly
represent the agent observed in supporting histopath-
ology [2]. In many cases, the etiology of skin infections
in snakes has likely been incorrectly attributed to com-
mon environmental microorganisms and such misdiag-
noses may lead to unsuccessful treatment regimens andl. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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such infections in captive snakes.
Fungi formerly grouped within the Chrysosporium
anamorph of Nannizziopsis vriesii (CANV) complex are
among the few species that have been repeatedly associ-
ated with dermatological disease in reptiles (summarized
by [2,4]), and at least one species has been shown
through infection trials to act as a primary pathogen in
healthy chameleons [5]. Recent phylogenetic analyses of
the CANV complex have revealed several new taxa [6,7].
One of these species, Ophidiomyces (formerly Chrysos-
porium) ophiodiicola, was described for the first time in
2009 after its isolation from a captive snake with a facial
granuloma [8]. However, upon re-examining isolates
formerly classified as CANV, Sigler et al. [6] found that
O. ophiodiicola has been associated with emerging skin
infections in captive snakes for the last several decades.
Many additional cases of dermatitis associated with O.
ophiodiicola are thought to have been incorrectly attrib-
uted to bacteria or other fungi [2], and O. ophiodiicola
may be one of the most common, albeit overlooked,
causes of skin infections in captive snakes.
Since 2006, O. ophiodiicola has also been isolated from
wild snakes with severe, and often fatal, infections in the
eastern U.S. [9,10]. These emerging infections, referred
to as snake fungal disease (SFD), are currently consid-
ered a serious threat to some snake populations [9,11].
However, recent attempts to study the prevalence, distri-
bution, and impacts of SFD on wild snakes have been
hampered by the lack of rapid, cost-effective, and reliable
laboratory tests to detect O. ophiodiicola.
Confirming presence of O. ophiodiicola in association
with skin lesions can be problematic due to the difficulty
of isolating the fungus in culture. Isolation is particularly
challenging when small samples such as biopsies or scale
clippings are collected, and euthanasia of the animal is
frequently required to obtain larger samples sufficient
for confirming the presence of O. ophiodiicola. Even
when the fungus is isolated in culture, identification of
O. ophiodiicola based on morphological characteristics is
often unreliable. Furthermore, the fungus is relatively
slow-growing such that the process of successful isola-
tion and identification can take weeks and may be
dependent upon laboratory expertise. Given the recent
emergence of SFD in wild snakes and the clinical import-
ance of fungal dermatitis in captive snakes, a rapid and
more sensitive tool for the detection of O. ophiodiicola
is needed.
Here we describe the development and qualification of
two TaqMan real-time polymerase chain reaction (PCR)
assays that reliably detect O. ophiodiicola from small
pieces of skin tissue collected from live snakes. The PCR
tests target either the multi-copy internal transcribed
spacer region (ITS) or intergenic spacer region (IGS) ofO. ophiodiicola and are extremely sensitive, highly spe-
cific, and yield results in less than 24 hours. These assays
offer utility in assisting with diagnosis of SFD in both
wild and captive snakes in addition to providing an im-
portant research tool for better understanding the biol-
ogy of the fungus and ecology of this disease.
Methods
DNA extraction, amplification, and sequencing
All fungal cultures were grown at 24°C on Sabouraud
dextrose agar containing chloramphenicol and gentamicin
or dermatophyte test medium. After 7 to 21 days (depend-
ing on the growth rate of a particular isolate), approxi-
mately 5 to 10 mg of mycelia were scraped off of the
medium and placed into 600 μl lyticase solution [1 M
sorbitol, 100 mM EDTA, 200 U lyticase (Sigma-Aldrich,
St. Louis, MO), and 14 mM beta-mercaptoethanol], ground
with a pestle, and incubated at 30°C and 500 rpm for
1 hour. Fungal protoplasts were pelleted by centrifugation
at 500 x g for 10 min, the supernatant removed, and gen-
omic DNA (gDNA) extracted using the Gentra®Puregene®
Tissue Kit (Qiagen Inc., Valencia, CA) according to the
“solid tissues protocol” and omitting proteinase K and
RNase treatments.
The gDNA extracted from isolates of O. ophiodiicola
used in this study (see Table 1) was quantified at the
University of Wisconsin Biotechnology Center using an
Invitrogen™ Qubit™ Fluorometer (Life Technologies,
Carlsbad, CA). To ensure that the gDNA extracted from
all other fungal isolates (i.e., non-O. ophiodiicola isolates
listed in Tables 1 and 2) was of sufficient quantity and
quality for downstream PCR applications, the internal
transcribed spacer region (ITS) was amplified using the
fungal-specific primers ITS1-F and ITS4 [12] under the
following cycling conditions: 94°C for 3 min; 40 cycles of
94°C for 1 min, 53°C for 1 min, and 72°C for 3 min; and
a final extension at 72°C for 10 min. GoTaq® Flexi DNA
polymerase (Promega Corporation, Madison, WI) was
used for the PCR reactions following the manufacturer’s
instructions, and 5 μl template (diluted 1:10) was added
per 25 μl reaction. All such reactions yielded strong
bands of the correct size, indicating that fungal gDNA
had been successfully extracted.
To generate sequence data for the IGS of O. ophiodii-
cola isolates, primers CNL12 [13] and CNS1 [14] were
used to amplify the approximately 2,800 bp region under
the following cycling conditions: initial denaturation at
98°C for 2 min; 47 cycles of 98°C for 10 sec, 50.5°C for
30 sec, and 72°C for 7 min; and a final extension of 72°C
for 7 min. Products were gel-purified using the QIA-
quick Gel Extraction Kit (Qiagen Inc., Valencia, CA) and
sequenced from both ends with primers CNL12 and
CNS1. A primer walking strategy was employed in an at-
tempt to sequence the entire IGS. However, repetitive
Table 1 Fungal isolates for which ribosomal RNA regions were analyzed to develop Ophidiomyces ophiodiicola-specific
PCR assays
GenBank Accession No.*
Isolate Species ITS Reference ITS IGS
CBS 122913 Ophidiomyces ophiodiicola [8] EU715819 KP691505
UAMH 6218 Ophidiomyces ophiodiicola [6] KF477227 KP691506
UAMH 6642 Ophidiomyces ophiodiicola [6] KC884267 KP691507
UAMH 6688 Ophidiomyces ophiodiicola [6] KF477228 KP691508
UAMH 9985 Ophidiomyces ophiodiicola [6] KF477230 KP691509
UAMH 10296 Ophidiomyces ophiodiicola [6] KF477232 KP691510
UAMH 10768 Ophidiomyces ophiodiicola [6] KF477234 KP691511
UAMH 10769 Ophidiomyces ophiodiicola [6] KF477235 KP691512
UAMH 10949 Ophidiomyces ophiodiicola [6] KF477236 KP691513
UAMH 11295 Ophidiomyces ophiodiicola [6] KF477237 KP691514
UAMH 10212 Chrysosporium indicum this study KP691483 KP691515
CBS 629.79 Chrysosporium sp. this study KP691484 KP691516
UAMH 10352 Nannizziopsis guarroi [6] KF477208 KP691517
UAMH 10417 Nannizziopsis infrequens [6,22] AY744467 KP691518
UAMH 3527 Nannizziopsis vriesii [6] KF477198 KP691519
UAMH 10439 Paranannizziopsis australasiensis [6] KF477218 KP691520
UAMH 10693 Paranannizziopsis californiensis [6] KF477224 KP691521
UAMH 8392 Pseudoamauroascus australiensis [23] AJ131787 KP691522
CBS = isolates obtained from the Centraalbureau voor Schimmelcultures.
UAMH = isolates obtained from the University of Alberta Microfungus Collection and Herbarium.
ITS = internal transcribed spacer region of the ribosomal RNA gene complex.
IGS = intergenic spacer region (3′ and 5′ ends) of the ribosomal RNA gene complex.
*All IGS DNA sequences were newly generated for this study.
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cult to sequence through certain regions, resulting in
successful sequencing of approximately 330 nucleotides
at the 5′-end of IGS and approximately 875 nucleotides
at the 3′-end. The 5′- and 3′-ends of the IGS for several
fungi that are closely related to O. ophiodiicola (Table 1)
were also amplified and sequenced as described above.
All newly generated sequences for this study (which in-
cluded sequences from 10 isolates of O. ophiodiicola and
eight species of closely related fungi) were deposited in
GenBank (Table 1).
Primer and probe design
The ITS and IGS of multiple strains of O. ophiodiicola,
along with selected near relatives (Table 1), were
aligned using MegAlign™ (Lasergene® 10, DNASTAR,
Madison, WI). For the ITS alignment, ITS-1 demon-
strated the greatest interspecific variability, but this
region also contained numerous single nucleotide poly-
morphisms (SNPs) between strains of O. ophiodiicola
and appeared to be an unsuitable target for the devel-
opment of an O. ophiodiicola-specific PCR capable of
detecting all strains of the fungus. ITS-2 was more con-
served among different strains of O. ophiodiicola butstill demonstrated interspecific divergence. Thus, ITS-2
was targeted for assay development. For the IGS align-
ment, both the 5′- and 3′-ends of the IGS sequence of
O. ophiodiicola were highly divergent from those of its
nearest neighbors’ (excluding portions of the sequences
that represented and flanked the 3′-end of the 28S
ribosomal RNA (rRNA) gene and the 5′-end of the 18S
rRNA gene; these areas were avoided for assay develop-
ment). Different strains of O. ophiodiicola shared high
identity within the IGS, but intraspecific variation was
observed at numerous SNPs throughout the regions se-
quenced. Areas of the IGS that were most conserved
among all evaluated strains of O. ophiodiicola were tar-
geted for development of an IGS PCR.
Primers and probes were designed using the online
PrimerQuest® program (Integrated DNA Technologies,
Coralville, IA) [15]. The qPCR option was selected and
design parameters were modified such that the pro-
gram chose primers with a minimum calculated melt-
ing temperature (Tm) of 57°C, an optimum Tm of 60°C,
and a maximum Tm of 65°C; probe Tm was set between
64°C and 75°C, with an optimum Tm of 70°C. Several
primer/probe sets meeting these criteria were identified
for both ITS and IGS; however, in each case the binding
Table 2 Fungal isolates from snakes that were used to
assess specificity of Ophidiomyces ophiodiicola PCR assays
Isolate Species* ITS GenBank
Accession No.
44736-30-02-02 Alternaria sp. KP691485
24411-01-01-02 Arthroderma/Trichophyton sp. KP691486
44736-44-01-01 Arthroderma/Trichophyton sp. KP691487
24833-01-01-01A Ascomycete sp. KP691488
24821-01-02-01 Aspergillus sp. KP691489
44736-02-01-01 Beauveria sp. KP691490
24392-01-03-04 Bionectria sp. KP691491
24266-04-05-01 Cladosporium sp. KP691492
24392-01-02-02 Hypocreales sp. KP691493
24415-01-02-02 Isaria sp. KP691494
24266-01-03-02 Metarhizium sp. KP691495
24266-01-01-01A Mucor sp. KP691496
44736-32-02-01 Myriodontium sp. KP691497
44736-01-01-01 Paecilomyces sp. KP691498
44736-43-05-04A Penicillium sp. KP691499
24281-01-01-01 Penicillium sp. KP691500
44736-32-01-01 Pseudogymnoascus sp. KP691501
44736-03-02-01 Purpureocillium lilacinum KP691502
24281-01-02-01 Trichocomaceae sp. KP691503
24826-01-01-01A Trichoderma sp. KP691504
*Identifications were based on DNA sequencing of the internal transcribed
spacer region (ITS).
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among strains of O. ophiodicola or resided within an
area where the oligos might bind to DNA from non-
target species. Thus, binding positions of some oligos
were modified slightly from the original PrimerQuest®
output such that they would bind more specifically to
DNA from O. ophiodiicola while also residing within re-
gions conserved among all analyzed strains of the
fungus. Potential formation of secondary structure, self-
binding, and Tm were also considered when designing
the oligos. The newly designed primer and probe se-
quences for the ITS assay were: Oo-rt-ITS-F (forward
primer) 5′-GAGTGTATGGGAATCTGTTTC-3′; Oo-
rt-ITS-R (reverse primer) 5′-GGTCAAACCGGAAAG
AATG-3′; Oo-rt-ITS-P (probe) 5′-(FAM)TCTCGCT
CGAAGACCCGATCG(BHQ-1)-3′. The newly designed
primer and probe sequences for the IGS assay were:
Oo-rt-IGS-F (forward primer) 5′-CGGGTGAATTACCC
AGTT-3′; Oo-rt-IGS-R (reverse primer) 5′-AGCCAT
CCTTCCCTACAT-3′; Oo-rt-IGS-P (probe) 5′-(FAM)
ATACTCTCCGGGCGCTTGTCTTCC(BHQ-1)-3′(Figure1).
All primers and probes were searched against the Gen-
Bank database using the Basic Local Alignment SearchTool (BLAST) [16]. No sequences in GenBank (exclud-
ing those of O. ophiodiicola) were a perfect match to the
primers or probes, and those sequences that were most
similar to a given oligo did not demonstrate significant
similarity with the other two oligos in the set.
Assay development
Real-time PCR was performed on the Applied Biosys-
tems® 7500 Fast Real-Time PCR System. Master mix
(QuantiFast Probe PCR + ROX Vial Kit, Qiagen, Inc,
Valencia, CA) was prepared according to the manufac-
turer’s specifications. Included in the 25 μl reaction vol-
ume was 12.5 μl 1X QuantiFast Probe Master Mix,
0.5 μl 1X ROX dye solution, 5 μl template DNA, 0.5 μl
of each 20 μM primer stock solution (final reaction
concentration 0.4 μM), 0.25 μl 20 μM probe stock
solution (final reaction concentration 0.2 μM), and
0.5 μl of 20 μg/μl Bovine Serum Albumin (BSA) solu-
tion (Sigma-Aldrich, St. Louis, MO; final reaction con-
centration of 0.4 μg/μl) to mitigate possible PCR
inhibitors. Oligos were synthesized by a commercial
company (BioSearch Technologies, Inc., Novata CA).
Standard cycling conditions were used for both assays:
95°C for 3 minutes, 95°C for 3 seconds, 60°C for 30 seconds
for a total of 40 cycles. To standardize cycle threshold (Ct)
values across PCR runs, the threshold was set at four
percent of the maximum background-subtracted fluor-
escence (ΔRn). At this threshold, sample amplification
curves approached maximum efficiency, negative con-
trols were below the threshold, and weak positives
exceeded the threshold. Efficiency along individual amp-
lification curves was determined by calculating the slope
of five consecutive ΔRn fluorescence readings [17].
Samples that crossed the threshold at ≤ 36 cycles for the
ITS assay and ≤ 38 cycles for the IGS assay were consid-
ered positive for diagnostic purposes. These threshold
cutoffs were selected because standard curve results in-
dicated that the assays performed inconsistently when
template DNA concentrations yielded Ct values above
36 and 38 for each assay, respectively. For each plate
run (including those for assay qualification), a negative
control (water added in place of template) and standard
curve of gDNA (5 X 105, 5 X 104, 5 X 103, 5 X 102, and
50 fg) isolated from the type isolate of O. ophiodiicola
(CBS 122913) were included.
The efficiency, precision, and detection limit of the PCR
assays were evaluated based on a ten-fold standard curve
dilution series of gDNA (5.0 ag to 5.0 ng) isolated from
the type isolate of O. ophiodiicola. Efficiency was calcu-
lated from the slope of the best fit line of Ct value plotted
against the log-transformed quantity (fg) of DNA tem-
plate, (efficiency = −1 + 10 (−1/slope)). The standard curve
was run in triplicate, and precision was evaluated based
on the expectation that the standard deviations not exceed
Figure 1 Diagram of fungal ribosomal RNA regions and areas targeted for Ophidiomyces ophiodiicola-specific real-time PCR assays. One assay
targets the 3′-end of the internal transcribed spacer region 2 (ITS-2) while the second assay targets the 3′-end of the intergenic spacer region
(IGS). Expanded sequences (representing the type isolate of O. ophiodiicola) show the amplicons produced by each PCR and the primer and
probe binding sites. Shaded boxes within the sequences represent nucleotide positions that vary between strains of O. ophiodiicola.
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tration at which all three replicates reliably amplified.
Assay qualification
Consistent detection assays should amplify and capture all
O. ophiodiicola genetic variants with minimal differences
in Ct values among those variants. To assess consistency
of the real-time PCR assays, 5 pg of gDNA from seven iso-
lates (CBS 122913, UAMH 6218, UAMH 6642, UAMH
6688, UAMH 9985, UAMH 10296, UAMH 10768; Table 1)
representing all known ITS and IGS sequence variants of
O. ophiodiicola were tested in duplicate.
To ensure that the assays were specific to O. ophio-
diicola, the primer and probe sets were tested against a
panel of eight closely related fungal species (Table 1).
These included several reptile-infecting taxa for which
phylogenetic relationships were recently resolved [6], a
Chrysosporium sp. isolated from a snake (CBS 629.79),
and other near neighbors within the Onygenales group.
The assays were also screened against representative
isolates of 20 fungal species that were commonly iso-
lated from the skin of snakes submitted to the U.S.
Geological Survey – National Wildlife Health Center
(NWHC) for diagnostic evaluation (Table 2).
The sensitivity of the real-time PCR assays were de-
termined using tissue samples collected from 70 wild
snakes with skin lesions from the eastern half of the
U.S. Samples originated from submissions to theNWHC that included snakes carcasses found in the
wild, snakes that were humanely euthanized, and non-
lethally collected skin biopsies. These samples ranged
from deep dermal granulomas and full cross-sections
of infected skin (collected from dead snakes or as biop-
sies) to superficial epidermal crusts (collected as scale
clippings or from lesions on shed skin). Corresponding
sections of tissue from 50 of the 70 snakes had tested
positive for O. ophiodiicola by culture analyses con-
ducted at the NWHC. Sections of snout, dorsal, and
ventral skin from 16 snakes without signs of skin infec-
tion and that had tested negative for the presence of
O. ophiodiicola by culture analyses were analyzed as
disease-negative samples. DNA was extracted from tis-
sues approximately 2 mm3 in size using the Gentra®-
Puregene® Tissue Kit, “solid tissues protocol”. For the
lysis procedure, 0.5 mg/ml proteinase K was added to
the lysis buffer containing tissue, and the mixture was
digested for 1.5 to 3 hours. Tissues were then macer-
ated with a pestle and further digested overnight. The
RNase treatment step was omitted, but the procedure
was otherwise carried out according to the manufac-
turer’s instructions. A negative control (no tissue added)
extraction was performed to ensure that reagents were
not contaminated. Extracted DNA was diluted ten-fold
and the diluted template used for real-time PCR as
described above. To test for inhibition, the snout, dor-
sal, and ventral skin DNA extracts of four randomly
Figure 2 Standard curves for Ophidiomyces ophiodiicola real-time PCR
assays. Genomic DNA (gDNA) isolated from a pure culture of the type
isolate of O. ophiodiicola was quantified, serially diluted, and used as
template. All samples were run in triplicate with all points depicting
mean Ct values and error bars representing standard deviation. The
assays targeting (A) the internal transcribed spacer region (ITS assay)
and (B) intergenic spacer region (IGS assay) of O. ophiodiicola were both
linear over seven logs, ranging from 5 fg to 5 ng template gDNA (ITS
assay: R2 = 0.998; IGS assay: R2 = 0.997).
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with 5 pg O. ophiodiicola gDNA. The Ct values of the
spiked samples were then compared to Ct values of the
5 pg standard curve replicates on the same plate to en-
sure that amplification was equivalent. The sensitivity of
each PCR was compared to that of the culture-based
analyses with McNemar’s Test in SigmaPlot 11.2 (Systat
Software, Inc., San Jose, CA).
Amplified DNA from 5 randomly selected PCR- and
culture-positive samples and all culture-negative sam-
ples that produced positive PCR results were sequenced
to confirm that the amplicons matched the targeted re-
gion. Briefly, amplicons were cloned using the Invitro-
gen™ TOPO® TA Cloning® Kit with the pCR™ 2.1-TOPO®
vector and TOP10 competent cells (Life Technologies,
Carlsbad, CA), the clones screened by PCR with vector-
specific primers, and the resulting PCR products se-
quenced according to the manufacturer’s instructions.
Ethics statement
All carcass collection, euthanasia, and biopsy sampling
procedures were performed under the authority of
other agencies in accordance with applicable state laws;
specimens were submitted for routine diagnostic ana-
lyses that did not require further review by NWHC in-
stitutional committees. Collection of scale clippings
from live snakes by NWHC personnel was conducted
under NWHC Institutional Animal Care and Use Com-
mittee protocol EP130117 and was done in compliance
with all necessary permissions and permitting require-
ments. Animals sampled for this study were wild and
not client-owned; thus no owner consent was required.
Results
Assay efficiency and precision
The standard curve efficiency of both the ITS and IGS
PCR assays were within the accepted range of 90%-
110% [18]. Specifically, the ITS standard curve was
101.41% efficient with an R2-value of 0.998. The IGS
standard curve had an efficiency of 95.02% and an
R2-value of 0.997 (Figure 2). All standard curve repli-
cates were precise, varying from one another by less
than one Ct value (standard deviations for replicates of
the ITS assay ranged from 0.08 to 0.49; those of the IGS
assay were between 0.09 and 0.44). The detection limit
for both assays was 5 fg of purified gDNA. The ITS
assay, on average, yielded Ct values that were 2.44 cycles
lower than that of the IGS assay.
Assay specificity and sensitivity
The specificities of the ITS and IGS assays were tested
using a panel of eight fungi closely related to O. ophiodii-
cola and 20 additional fungi that are commonly associated
with snake skin. No discernible amplification was detectedwhen DNA extracted from these fungi were used as tem-
plate. The assays did, however, amplify target DNA from
all known genetic variants of O. ophiodiicola. The Ct
values among these variants were very similar (standard
deviations of 0.63 and 0.64 for the ITS and IGS assays, re-
spectively), indicating that performance of the PCR did
not vary by strain.
Both assays also performed identically when they were
used to screen snake tissue samples for the presence of
O. ophiodiicola. Forty-nine of the 50 (98%) tissue sam-
ples that were culture-positive for O. ophiodiicola were
also positive by PCR. The remaining sample showed no
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a Ct of 39.12 with the IGS assay (above the 38 cycle cut-
off ). Eight of the 20 tissue samples from snakes that had
gross lesions suggestive of SFD but that were culture-
negative for O. ophiodiicola were PCR-positive. One
additional sample had a Ct of 38.76 with the IGS assay,
but all other samples yielded no amplification. Of the 48
total samples from animals without clinical signs of SFD
(3 pieces of skin from each of 16 snakes), a single sample
(snout skin from one snake) was PCR-positive by both
assays. An additional sample (dorsal body skin) from the
same animal, as well as ventral body skin from a second
animal, demonstrated amplification with the ITS assay,
but had Ct values over 36. No amplification was ob-
served in the negative extraction control sample. The in-
ability of the two assays to perform equivalently at high
Ct values and the questionable clinical significance of ex-
tremely low levels of O. ophiodiicola DNA further dem-
onstrated the practicality of setting the Ct threshold at
36 (ITS assay) and 38 (IGS assay) for diagnostic pur-
poses. When the two detection methods were compared,
the PCR assays proved to be more sensitive than
culture-based detection methods (χ2 = 4.900, p = 0.027).
For all runs, negative controls performed as expected
and standard curves were linear. The Ct values of the
spiked negative extracts were within one Ct of the
standard curve replicates containing the same amount
of gDNA; thus, there was no evidence of inhibition. All
PCR products that were sequenced were 100% identical
to the desired ITS or IGS amplicons, indicating the
positive results were not due to cross-amplification of
non-target DNA.
Discussion
Advances in diagnostics and research related to O.
ophiodiicola and its associated infections have been
hampered by lack of reliable and sensitive techniques to
detect the fungus. We designed two real-time PCR
methods to rapidly identify the fungus in clinical sam-
ples. Both PCR assays proved to be more sensitive than
culture-based methods for detecting O. ophiodiicola.
Specifically, PCR yielded negative results for only 2% of
samples that were culture-positive for O. ophiodiicola;
and detected the fungus in 8 of 20 (40%) culture-negative
samples that had been collected from snakes with clinical
signs suggestive of SFD. In four of the remaining 12
snakes with grossly visible skin infections that were
culture- and PCR-negative, fungi possessing morpho-
logical characteristics inconsistent with O. ophiodiicola
were observed by histopathology; in three additional
samples, fungi consistent with O. ophiodiicola were seen
but could not be definitively identified microscopically;
and the five remaining samples consisted of scale clip-
pings and thus were unsuitable for histopathologicexamination. Since no “gold standard” method for de-
tection of O. ophiodiicola currently exists, it is difficult
to ascertain whether other microorganisms caused most
of the infections that were PCR-negative. Bacteria, other
fungi, and noninfectious processes are known to cause
clinical signs that are grossly indistinguishable from
those associated with O. ophiodiicola [2], and it is likely
that at least some PCR-negative samples represented in-
fections caused by other etiological agents. In histopath-
ology, the cutaneous fungal invasion that characterizes
SFD is often localized. Thus, it is also possible that div-
iding tissues for different types of analyses may have
resulted in allocation of tissue for PCR that did not cap-
ture the active lesion or contained insufficient numbers
of fungal elements. This likely explains the 2% false-
negative rate for culture-positive samples and highlights
the importance of targeting an active area of the lesion
for PCR testing. Nonetheless, these data indicate that
the PCR assays represent the most sensitive tool cur-
rently available to detect O. ophiodiicola.
In our PCR screen, one of 16 (~6%) snakes without
clinical signs of SFD tested positive for O. ophiodiicola
(Ct values of 29.16 and 30.94 for the ITS and IGS PCR
assays, respectively). To rule out contamination as a
source of these PCR-positive results, we sampled add-
itional tissues from the same animal (i.e., chin skin, spec-
tacle, and two pieces of snout skin). PCR indicated that
O. ophiodiicola was also present on the chin skin and
spectacle, suggesting that contamination was an unlikely
explanation for the positive results. A sample from one
additional snake without lesions that was classified as
PCR-negative also showed evidence of amplification
above the diagnostic threshold cut-off. Sequenced ampli-
cons of the PCR-positive snake without clinical signs of
infection and of the additional culture-negative snake
with a Ct value above the diagnostic cut-off (neither of
which were suspected to have had SFD) were a 100%
match to O. ophiodiicola. Whether such detections repre-
sent early stages of colonization/infection by the fungus or
indicate the potential of some snakes to harbor low levels
of O. ophiodiicola in the absence of disease manifestation
is unclear, but the latter seems more plausible. Paré et al.
[3] reported culturing O. ophiodiicola from shed skin of
less than 1% of captive snakes without clinical signs of
skin infection, and the authors speculated that the fungus
occurs only rarely on asymptomatic animals. However,
the low detection rate in that study may have been
due to the insensitivity of culture techniques, particu-
larly when the fungus is at low abundance. With its
much greater sensitivity, PCR has great utility in re-
search aimed at better parsing out the association
between O. ophiodiicola and disease, prevalence of the
fungus on asymptomatic animals, and the importance of
pathogen load in disease development.
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sist with identification of O. ophiodiicola-associated in-
fections in the clinical setting. The rapid turnaround
time of PCR (less than 24 hours) can provide important
preliminary results that allow for immediate treatment
of animals suspected to have SFD, can be used to help
verify whether fungal hyphae observed in histopathology
are O. ophiodiicola, and will provide an alternative to
morphological- or DNA sequencing-based identification
of pure cultures of O. ophiodiicola. Although the fungus
may occasionally be detected on the skin of snakes that do
not have SFD, animals with gross lesions tend to have
heavier burdens of O. ophiodiicola. For example, based on
average Ct values, snakes with infections known to be as-
sociated with O. ophiodiicola (i.e., culture-positive) had
approximately 1,000 times more O. ophiodiicola DNA de-
tected in their tissues than PCR-positive snakes without
clinical signs of SFD. When the active lesion is sampled,
Ct values can generally be expected to be low if O. ophio-
diicola is associated with the infection. Furthermore,
snakes with severe skin infections typically have multiple
lesions on the body that can be non-lethally sampled. By
sampling more than one lesion (or several areas of a single
large lesion), clinicians can be confident that PCR results
represent true-positive or true-negative detections.
While the PCR assays we describe are useful diagnos-
tic tools, it is important to note that histopathology in
conjunction with PCR is necessary to make definitive
diagnoses that accurately distinguish disease from mere
presence of the pathogen. However, there are applica-
tions in which simply confirming the presence of
O. ophiodiicola (irrespective of actual disease) may be
useful. For example, PCR would provide a much more
sensitive method to screen for asymptomatic carriers of
the fungus during the importation and quarantine
process at zoological parks and reptile collections as
well as to screen environmental samples for potential
contamination with O. ophiodiicola. For such applica-
tions, laboratories may wish to set the PCR threshold at
40 or more cycles to detect very low levels of the fun-
gus. In addition, multiple samples should be tested to
reduce the likelihood of false-negative results.
Both PCR assays described in this report target portions
of the rRNA gene complex. This gene region occurs as
multiple copies within the fungal genome, affording high
sensitivity to assays that target the rRNA gene complex.
For example, Muller et al. [19] estimated that the lower
limit of detection of a real-time PCR assay specific to the
IGS of Pseudogymnoascus destructans (the causative agent
of bat white-nose syndrome) was approximately 0.1 gen-
ome equivalents. At this time, neither the number of cop-
ies of rRNA genes on, nor the size of, the O. ophiodiicola
genome is known, making it difficult to predict the
lower limit of detection in genome equivalents. However,detection limits based on purified gDNA were similar be-
tween our assays and that of Muller et al. [19]. Different
strains of O. ophiodiicola apparently have a similar num-
ber of rRNA gene region copies as Ct values were consist-
ent between them when known amounts of gDNA were
used as template. This indicates that the PCR assays have
great potential for research that requires quantification of
the fungus in samples. However, more work is necessary
to more definitively determine how Ct values translate to
cell-equivalents.
The overall performance of the ITS and IGS assays
were similar, but each assay is optimally suited for dif-
ferent applications. The ITS assay is the more robust
option for diagnostic work, particularly for laboratories
that may be receiving samples from captive snakes. Al-
though both assays performed well against all currently
known strains of O. ophiodiicola, there are undoubtedly
more strains yet to be characterized. The more highly
conserved nature of ITS between strains, however,
makes the ITS assay more likely to detect novel and po-
tentially divergent genetic variants of O. ophiodiicola.
Such variants are more likely to be encountered in cap-
tive snakes or wild snakes from outside eastern North
America (since most characterized strains upon which
the assays were designed originated in the eastern
U.S.). The IGS exhibits greater DNA sequence variation
between strains, increasing the possibility that novel
genetic variants may have SNPs in oligo binding sites
within the IGS. Thus while there is no evidence to indi-
cate that the IGS assay is unsuitable for diagnostic
work, the use of the ITS assay for this purpose repre-
sents the more conservative approach.
For screening environmental samples for O. ophiodii-
cola, the IGS assay is recommended. While both assays
discriminated between O. ophiodiicola and its closest
known relatives, we cannot rule out the possibility that
there are other uncharacterized environmental fungi
that are genetically similar to O. ophiodiicola and that
could cross-react with the ITS assay primers and probe.
For example, CANV complex species within polytypic
genera (e.g., Nannizziopsis and Paranannizziopsis) may
share over 97% DNA sequence identity in the ITS [6]; if
such small differences in ITS sequences existed between
O. ophiodiicola and other hypothetical species of Ophi-
diomyces, the ITS assay would be unlikely to differenti-
ate them. While sequencing of amplicons in this study
indicated no evidence that such closely-related fungi
exist on the skin of snakes, environmental samples may
harbor much more diverse fungal communities. For
example, the original ITS-based PCR used to detect
P. destructans performed well when testing bat tissues,
but was unsuitable for discriminating the pathogen from
a wide variety of closely-related, nonpathogenic, and
previously undiscovered Pseudogymnoascus spp. in soil
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opment of a more specific PCR assay targeting the IGS
of P. destructans which exhibits much higher interspe-
cific variation than the ITS [19]. Such high variation in
the region makes it highly unlikely that the IGS assay
described herein would cross-amplify DNA from fungi
other than O. ophiodiicola, including very closely related
hypothetical taxa that are yet to be discovered. The IGS
assay also has utility for research that requires differenti-
ation among strains of O. ophiodiicola – because the
amplicon produced by the IGS PCR encompasses numer-
ous SNPs (Figure 1), sequencing the amplicon can distin-
guish between some genetic variants of the fungus.
Conclusions
The increase of CANV-associated infections in captive rep-
tiles and the emergence of SFD in wild snakes have elicited
concern over the future health of both captive and wild
snake populations. As clinicians attempt to diagnose an in-
creasingly common disease and researchers attempt to bet-
ter understand the disease system, enhanced methods to
detect the fungus linked to these infections will be essen-
tial. The PCR assays described herein provide important
tools to advance SFD diagnostics, support surveillance ef-
forts, and aid researchers trying to better understand the
biology of O. ophiodiicola, the intricacies of host-pathogen
dynamics, and the drivers of SFD emergence.
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